SEMA4D
Semaphorin-4D
Also known as: C9orf164, CD100, coll-4, FLJ39737, SEM4D_HUMAN, SEMAJ
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92854
- Gene
- SEMA4D
- Ensembl
- ENSG00000187764
- Chromosome
- 9
- Canonical length
- 862 aa
- Protein class
- CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane,Primary cilium transition zone,Centrosome,Basal body
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables identical protein binding activity; semaphorin receptor binding activity; and transmembrane signaling receptor activity. Involved in several processes, including positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; regulation of neuron projection development; and regulation of primary metabolic process. Located in microtubule organizing center; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
862 residues, UniProt reviewed canonical sequence.
>Q92854|SEMA4D
1 MRMCTPIRGL LMALAVMFGT AMAFAPIPRI TWEHREVHLV QFHEPDIYNY SALLLSEDKD
61 TLYIGAREAV FAVNALNISE KQHEVYWKVS EDKKAKCAEK GKSKQTECLN YIRVLQPLSA
121 TSLYVCGTNA FQPACDHLNL TSFKFLGKNE DGKGRCPFDP AHSYTSVMVD GELYSGTSYN
181 FLGSEPIISR NSSHSPLRTE YAIPWLNEPS FVFADVIRKS PDSPDGEDDR VYFFFTEVSV
241 EYEFVFRVLI PRIARVCKGD QGGLRTLQKK WTSFLKARLI CSRPDSGLVF NVLRDVFVLR
301 SPGLKVPVFY ALFTPQLNNV GLSAVCAYNL STAEEVFSHG KYMQSTTVEQ SHTKWVRYNG
361 PVPKPRPGAC IDSEARAANY TSSLNLPDKT LQFVKDHPLM DDSVTPIDNR PRLIKKDVNY
421 TQIVVDRTQA LDGTVYDVMF VSTDRGALHK AISLEHAVHI IEETQLFQDF EPVQTLLLSS
481 KKGNRFVYAG SNSGVVQAPL AFCGKHGTCE DCVLARDPYC AWSPPTATCV ALHQTESPSR
541 GLIQEMSGDA SVCPDKSKGS YRQHFFKHGG TAELKCSQKS NLARVFWKFQ NGVLKAESPK
601 YGLMGRKNLL IFNLSEGDSG VYQCLSEERV KNKTVFQVVA KHVLEVKVVP KPVVAPTLSV
661 VQTEGSRIAT KVLVASTQGS SPPTPAVQAT SSGAITLPPK PAPTGTSCEP KIVINTVPQL
721 HSEKTMYLKS SDNRLLMSLF LFFFVLFLCL FFYNCYKGYL PRQCLKFRSA LLIGKKKPKS
781 DFCDREQSLK ETLVEPGSFS QQNGEHPKPA LDTGYETEQD TITSKVPTDR EDSQRIDDLS
841 ARDKPFDVKC ELKFADSDAD GDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SEMA4D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 326 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 326 nTPM
- midbrain: 124 nTPM
- skeletal muscle: 83 nTPM
- hippocampal formation: 78 nTPM
- basal ganglia: 60 nTPM
- lymph node: 58 nTPM
Single-cell type
- neutrophils: 757 nCPM
- oligodendrocytes: 483 nCPM
- esophageal apical cells: 270 nCPM
- t-cells: 239 nCPM
- microglia: 235 nCPM
- platelets: 220 nCPM
Immune cell
- eosinophil: 38 nTPM
- neutrophil: 37 nTPM
- naive CD8 T-cell: 23 nTPM
- gdT-cell: 22 nTPM
- naive CD4 T-cell: 20 nTPM
- memory CD8 T-cell: 19 nTPM
Brain region
- white matter: 490 nTPM
- medulla oblongata: 313 nTPM
- pons: 276 nTPM
- basal ganglia: 273 nTPM
- midbrain: 270 nTPM
- cerebellum: 237 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- bone trabecula morphogenesis
- cell adhesion
- immune response
- negative chemotaxis
- negative regulation of apoptotic process
- negative regulation of cell adhesion
- negative regulation of osteoblast differentiation
- negative regulation of transcription by RNA polymerase II
- neural crest cell migration
- ossification involved in bone maturation
- positive regulation of cell migration
- positive regulation of collateral sprouting
- positive regulation of GTPase activity
- positive regulation of inhibitory synapse assembly
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein phosphorylation
- positive regulation of Rho protein signal transduction
- regulation of cell projection organization
- regulation of cell shape
- regulation of dendrite morphogenesis
- semaphorin-plexin signaling pathway
- leukocyte aggregation
Molecular functions
- chemorepellent activity
- identical protein binding
- neuropilin binding
- receptor ligand activity
- semaphorin receptor binding
- signaling receptor activity
- signaling receptor binding
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sema domain
- Plexin repeat
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin-like beta-sandwich domain
- Immunoglobulin-like fold
- WD40/YVTN repeat-like-containing domain superfamily
- PSI domain
- Semaphorin
- Immunoglobulin-like domain superfamily
- Sema domain superfamily
- Immunoglobulin domain
- Sema domain
- Plexin repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SEMA4D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SEMA4D as an antibody target. Whether an autoantibody or antibody against SEMA4D could matter depends on whether native SEMA4D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SEMA4D is annotated at the cell surface, where native SEMA4D is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SEMA4D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...